Pulmonary fibrosis deaths in the United States, 1979-1991: An analysis of multiple-cause mortality data

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 5, 1996, Pages 1548-1552

  Mannino, David M ^a,b   Etzel, Ruth A ^a   Gibson Parrish, R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HEALTH STATISTICS; HUMAN; INFANT; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 0029947194     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.5.8630600     Document Type: Article

References (15)

1. Crystal, R. G, P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166, 235-244.
2. Coultas, D. B., R. E. Zumwalt, W. C. Black, and R. E. Sobonya. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150:967-972.
3. Johnston, I., J. Britton, W. Kinnear, and R. Logan. 1990. Rising mortality from cryptogenic fibrosing alveolitis. B.M.J. 301:1017-1021.
4. Hubbard, R. B., J. R. Britton, D. B. Coultas, and I. Johnston. 1993. Trends in reported mortality from cryptogenic fibrosing alveolitis in three countries (abstract). Am. Rev. Respir. Dis. 148:A878.
5. Israel, R. A., H. M. Rosenberg, and L. R. Curtin. 1986. Analytical potential for multiple cause-of-death data. Am. J. Epidemiol. 124: 161-179.
6. Panos, R. J., R. L. Mortenson, S. A. Niccoli, and T. E. King. 1990. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am. J. Med. 88:396-403.
7. U.S. Public Health Service. 1980. International Classification of Diseases, Ninth Revision. U.S. Government Printing Office, Washington, DC. DHHS Publication No. (PHS) 80-1260.
8. Centers for Disease Control and Prevention. 1993. Advance Report of Final Mortality Statistics, 1991. Centers for Disease Control and Prevention, Atlanta, GA. Monthly Vital Statistics Report. 42:56-61.
9. Iwai, K., T. Mori, N. Yamada, M. Yamaguchi, and Y. Hosoda. 1994. Idiopathic pulmonary fibrosis: epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. Care Med. 150:670-675.
10. Scott, J., I. Johnston, and J. Britton. 1990. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. B.M.J. 301:1015-1017.
11. Turner-Warwick, M., B. Burrows, and A. Johnson. 1980. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 35:171-180.
12. Auerbach, O., A. P. Stout, E. C. Hammond, and L. Garfinkel. 1963. Smoking habits and age in relation to pulmonary changes. N. Engl. J. Med. 269:1045-1054.
13. Weiss, W. 1969. Cigarette smoking and diffuse pulmonary fibrosis. Am. Rev. Respir. Dis. 99:67-72.
14. Schwartz, D. A., D. S. Van Fossen, C. S. Davis, R. A. Helmers, C. S. Dayton, L. F. Burmeister, and G. W. Hunninghake. 1994. Determinants of progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 149:444-449.
15. Centers for Disease Control and Prevention (CDC). 1994. Trends and Recent Patterns in Selected Tobacco-Use Behaviors - United States, 1900-1993. MMWR CDC Surveill. Summ. 43:1-42.